In late July 2025, a rumor spread widely across social media platforms that billionaire investor Bill Gates received approval ...

Sitting at a market cap of $6.8 billion, Ionis Pharmaceuticals (IONS) is a U.S.-based biotech company that develops ...

Arrowhead's subsidiary Visirna has entered an agreement with Sanofi for plozasiran, a potential treatment for hypertriglyceridemia.

Natural products have been an inspiration for the development of new pharmaceuticals with nearly half of all present small-molecule drugs designed or derived based on some natural compound.

The global pharmaceutical lipids market is set for significant expansion, with a new forecast projecting a value of USD9.0 billion by 2035, growing from USD5.4 billion in 2025 at a compound annual ...

QuantumScale Single Cell RNA kits are already powering the analysis of millions of cells from Scale Bio’s “100 Million Cell Challenge,” a global initiative aimed at pushing the boundaries of ...

Viome Life Sciences Secures $86.5M for At-home Tests and Health Products Viome Life Sciences' Series C funding round included participation from Khosla Ventures, Bold Capital and WRG Ventures.